1-(methylsulfonyl)-4-(pyridin-2-yl)piperazine | 496777-28-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪烷类
• 英文名称: 1-(methylsulfonyl)-4-(pyridin-2-yl)piperazine
• 英文别名: 1-(methylsulfonyl)-4-(2-pyridinyl)piperazine；1-Methanesulfonyl-4-(pyridin-2-yl)piperazine；1-methylsulfonyl-4-pyridin-2-ylpiperazine
• CAS: 496777-28-7
• 化学式: C₁₀H₁₅N₃O₂S
• mdl: MFCD03621345
• 分子量: 241.314
• InChiKey: YQXBIPHWAMIXEM-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.4
• 重原子数：
  16
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  61.9
• 氢给体数：
  0
• 氢受体数：
  5

反应信息

• 作为产物：
  描述：

  1-(2-吡啶基)哌嗪 、 甲基磺酰氯 在 polymer-supported N-methylmorpholine 作用下， 以 二氯甲烷 为溶剂， 反应 16.0h， 以83%的产率得到1-(methylsulfonyl)-4-(pyridin-2-yl)piperazine
  参考文献：
  名称：

  Synthesis and solid state study of pyridine- and pyrimidine-based fragment libraries

  摘要：

  A library of pyridines and pyrimidines has been synthesised in excellent yields employing microwave and flow chemistry methodologies. Work-up bottlenecks have been facilitated substantially by the use of supported reagents and many of the final compounds have been studied in the solid state by single crystal X-ray diffraction. Crown Copyright (C) 2011 Published by Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tetlet.2011.07.147

文献信息

• Sulfonamide compounds as cysteine protease inhibitors
  申请人：Woo Soon H.

  公开号：US20090233909A1

  公开（公告）日：2009-09-17

  The present invention is directed to compounds of formula (I) that are inhibitors of cysteine proteases, in particular, cathepsins B, K, L, F, and S and are therefore useful in treating diseases mediated by these proteases. The present invention is directed to pharmaceutical compositions comprising these compounds and processes for preparing them. Wherein R3 is -alkylene-SO2NR5R6.

  本发明涉及式(I)的化合物，其为半胱氨酸蛋白酶的抑制剂，特别是对于B、K、L、F和S型的猫蛋白酶，因此可用于治疗这些蛋白酶介导的疾病。本发明涉及含有这些化合物的制药组合物以及制备这些化合物的过程。其中R3为-烷基-SO2NR5R6。
• Sulfonyl Amino Cyclic Derivatives and Use Thereof
  申请人：Swinnen Dominique

  公开号：US20080194520A1

  公开（公告）日：2008-08-14

  The present invention is related to derivatives of Formula (I) and use thereof in particular for the treatment and/or prophylaxis of autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, cancer, respiratory diseases and fibrosis, including multiple sclerosis, arthritis, emphysema, chronic obstructive pulmonary disease, liver and pulmonary fibrosis.

  本发明涉及公式（I）的衍生物及其在特定疾病的治疗和/或预防中的应用，特别是在自身免疫性疾病、炎症性疾病、心血管疾病、神经退行性疾病、癌症、呼吸系统疾病和纤维化等方面的应用，包括多发性硬化症、关节炎、肺气肿、慢性阻塞性肺疾病、肝纤维化和肺纤维化。
• SULFONYL AMINO CYCLIC DERIVATIVES AND USE THEREOF AS MMP INHIBITORS
  申请人：LABORATOIRES SERONO S.A.

  公开号：EP1828160A1

  公开（公告）日：2007-09-05
• SULFONAMIDE COMPOUNDS AS CYSTEINE PROTEASE INHIBITORS
  申请人：ViroBay, Inc.

  公开号：EP1819667B1

  公开（公告）日：2012-10-17
• US7973039B2
  申请人：——

  公开号：US7973039B2

  公开（公告）日：2011-07-05